Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring HIV Antibodies, Immunity, Cellular, Drug Therapy, Combination, Anti-HIV Agents, remune, HIV Therapeutic Vaccine
Eligibility Criteria
Inclusion Criteria Patients may be eligible for this study if they: Are HIV-positive and started anti-HIV drugs soon after tests showed the presence of HIV. Have been on an anti-HIV drug combination that includes a protease inhibitor for at least 3 months but no longer than 12 months. Have 2 consecutive viral loads of less than 50 copies/ml, at least 30 days apart, within 90 days of study entry. Are at least 16 years old (consent of parent or guardian required if under 18 years). Agree to practice abstinence or use effective methods of birth control during the study. Exclusion Criteria Patients will not be eligible for this study if they: Are pregnant or breast-feeding. Currently abuse alcohol or drugs. Are currently being treated for some types of cancer. Have any illness or condition that might interfere with the study or put them at risk. Have received a vaccination 6 weeks before study entry. Have previously received Remune. Are taking medications that affect the immune system within 30 days of study entry.
Sites / Locations
- Joanne Santangelo